Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;65(5):653-60.
doi: 10.1111/j.1365-2125.2008.03102.x. Epub 2008 Feb 20.

Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006

Affiliations

Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006

Anders Engeland et al. Br J Clin Pharmacol. 2008 May.

Abstract

What is already known about this subject: Mothers are using medicines during pregnancies; the extent varies across the world and is generally difficult to compare. In this registry-based study, we examined more than 100,000 Norwegian pregnancies and described the drug prescription pattern of both fathers and mothers around conception and during pregnancy (mothers).

What this study adds: In every trimester of pregnancy, about 30% of the mothers was dispensed a drug. The total drug exposure did not seem to diminish throughout pregnancy. One-quarter of the fathers was dispensed drugs during the last 3 months prior to conception.

Aims: The primary aim of this study was to describe the use of prescribed drugs in both mothers and fathers before and during pregnancy in Norway.

Methods: This population-based cohort study was based on data retrieved from the Medical Birth Registry of Norway and the Norwegian Prescription Database. These registries cover the entire population of Norway. Information on >100,000 births during 2004-2006 in the birth registry was linked to prescription data. Prescriptions issued to mothers just prior to, during and after the pregnancies as well as prescriptions to fathers just prior to conception were identified.

Results: Among mothers, 83% were prescribed drugs during the period 3 months prior to estimated conception until 3 months after giving birth. The mothers who received drugs were prescribed on average 3.3 different Anatomical Therapeutic Chemical (ATC) codes (range 1-38). During pregnancy, 57% were prescribed drugs. In the first trimester, 33% of mothers were dispensed drugs, while the figure was 29% for mothers in the last trimester. Among fathers, 25% used prescribed drugs during the 3 months prior to conception, with on average 1.9 different ATC codes (range 1-22).

Conclusion: Large proportions of both fathers and mothers were dispensed drugs prior to conception or during pregnancy. While there is a high awareness of the issues involved in maternal drug use in pregnancy, possible teratogenic effects of drug use in fathers shortly before conception should be further explored.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of mothers who had dispensed prescriptions 3 months prior to pregnancy to 3 months after pregnancy (based on n = 106 329 pregnancies). (All drugs, (▪); Excl. Contraceptives, (□))
Figure 2
Figure 2
Percentage of women who had dispensed prescriptions for three categories of drugs, defined by Bakker et al.[4], from 3 months prior to pregnancy to 3 months after pregnancy (based on n = 106 329 pregnancies). (Drugs for chronic conditions, (▪); Drugs for occasional and short-time use, (□); Pregnancy-related drugs, (•))

References

    1. Källén BAJ. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom (Kyoto) 2005;45:44–51. - PubMed
    1. Koren G. Ethical framework for observational studies of medicinal drug exposure in pregnancy. Teratology. 2002;65:191–5. - PubMed
    1. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128–37. - PubMed
    1. Bakker MK, Jentink J, Vroom F, van den Berg PB, de Walle HE, de Jong-van den Berg LT. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. Br J Obstet Gynaecol. 2006;113:559–68. - PubMed
    1. Trasler JM, Doerksen T. Teratogen update: paternal exposures-reproductive risks. Teratology. 1999;60:161–72. - PubMed

MeSH terms